Authors and Affiliates
Laahn Foster 1✉, Larry D. Anderson Jr 2
, Alfred Chung3
, Chakra P. Chaulagain 4
, Erin Pettijohn5
, Andrew J. Cowan6
,
Caitlin Costello7
, Sarah Larson8
, Douglas W. Sborov 9
, Kenneth H. Shain10, Rebecca Silbermann11, Peter Voorhees 12,
Maria Krevvata13, Huiling Pei14, Sharmila Patel15, Vipin Khare15, Annelore Cortoos15, Robin Carson13, Thomas S. Lin15 and
Ashraf Badros16
1
Division of Hematology Oncology, University of Virginia, Charlottesville, VA, USA. 2
Myeloma, Waldenstrom’s and Amyloidosis Program, Simmons Comprehensive Cancer Center,
UT Southwestern Medical Center, Dallas, TX, USA. 3
Department of Medicine, University of California San Francisco, San Francisco, CA, USA. 4
Department of Hematology and
Oncology, Myeloma and Amyloidosis Program, Cleveland Clinic Florida, Weston, FL, USA. 5
Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI, USA. 6
Division
of Medical Oncology, Fred Hutch Cancer Center/University of Washington, Seattle, WA, USA. 7
Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. 8
Division
of Hematology and Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. 9
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. 10Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. 11Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. 12Levine
Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC, USA. 13Johnson & Johnson, Spring House, PA, USA. 14Johnson & Johnson, Titusville, NJ,
USA. 15Johnson & Johnson, Horsham, PA, USA. 16Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
